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Summary  Long-term  seroprevalence  studies  of  dengue  have  provided  a  measure
of  the  degree  of  endemicity  and  future  trends  in  disease  prevalence  and  severity.  In
this  study,  we  describe  the  seroprevalence  of  dengue  antibodies  in  febrile  persons
with  suspected  acute  dengue  in  Barbados.  It  is  a  retrospective  population-based
study  of  all  febrile  persons  with  suspected  dengue  from  2006  to  2013.  All  of  the
cases  had  IgM  and  IgG  antibodies  in  the  blood  sample  drawn  between  days  3  and  5  of
their  illness.  Among  the  8296  cases  that  were  tested  for  IgM  antibodies,  3037  (36.6%)
had  recent  dengue  infection.  In  the  age  groups  <5  years,  5—20  years  and  >20  years,
23.3%,  39.6%  and  35.5%  had  acute  infection,  respectively.  Of  the  7227  cases  with
documented  IgG  results,  5473  (75.7%)  were  positive  and  had  a  past  infection.  In  the
age  groups  <5  years,  5—20  years  and  >20  years,  31.2%,  65.2%  and  86.6%,  respectively,
had  a  past  infection  (IgG  positive).  During  the  ﬁrst  5  years  of  life,  10—20%  of  febrile
persons  investigated  for  dengue  had  a  positive  IgM  and  a negative  IgG  titer,  between
5  and  10%  had  a  positive  IgM  and  IgG  titer,  5%  had  a positive  IgG  and  a  negative
IgM  titer,  and  between  45%  and  65%  had  a  negative  IgM  and  a  negative  IgG  titer.
Throughout  the  study  period,  between  12%  and  20%  of  febrile  persons  failed  to  show
any  evidence  of  current  or  previous  dengue.  In  the  age  groups  <5  years,  5—20  years
and  >20  years,  45.0%,  18.8%  and  7.2%,  respectively,  had  no  evidence  of  recent  or
past  dengue  (both  IgM  and  IgG  negative).  Between  37%  and  59%  of  the  febrile  persons
had  serological  evidence  of  past  dengue  in  the  absence  of  any  current  dengue.  In
conclusion,  the  pattern  of  IgG  antibodies  in  this  study  was  comparable  to  those  in
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Introduction
Infection  with  any  of  the  four  serotypes  of  dengue
(DENV 1—4)  results  in  a  spectrum  of  manifestations
from asymptomatic  to  severe  dengue,  which  can  be
fatal if not  detected  and  treated  early.  Sequential
(secondary or  tertiary)  infection  with  a different
dengue serotype  can,  in  some  instances,  result  in  a
severe form  of  dengue,  such  as  DHF  [1—5]. Dengue
has been  hyperendemic  in  southeast  Asia  since  the
1950s. All  four  serotypes  circulate  in  the  popula-
tion, and  there  is  a  high  dengue  seroprevalence
with a  high  incidence  of  DHF  [6].  In  Latin  America
and the  Caribbean,  dengue  re-emerged  as  a  public
health problem  in  the  1980s,  with  almost  all  ter-
ritories  reporting  circulation  of  all  four  serotypes
by the  early  1990s  [7—9].  In general,  the  trans-
mission of  dengue  (the  endemicity)  in  this  region
is thought  to  be  lower  with  fewer  reported  cases
of DHF  compared  to  the  situation  in  southeast
Asian countries.  However,  more  recent  studies  from
some of  the  countries  in  the  Americas  including
the Caribbean  have  demonstrated  that  most  dengue
cases presenting  to  hospitals  and  health  centers
were secondary  cases,  suggesting  a much  higher
transmission  or  endemicity  than  previously  thought
[10—13].
Seroepidemiological  studies  provide  a  measure
of the  endemicity  of  dengue.  Additionally,  they
are useful  in  predicting  epidemics  of  the  more
severe disease  forms.  Although  a  population-based
seroepidemiological  study  would  yield  much  more
valid results,  limited  resources  in  these  settings
are a  constraint  for  such  studies.  There  are  only
a few  short-term  dengue  seroepidemiological  stud-
ies from  the  English  Caribbean  [12—15].  Barbados,
one of  the  eastern  Caribbean  countries  with  a pop-
ulation of  284,600  in  2013  [16], has  a  fairly  efﬁcient
primary  and  tertiary  health  care  network,  both
in the  public  and  the  private  sector,  with  good
inter-sectorial cooperation  in  health  care  delivery.
There  is  an  active  surveillance  system  for  dengue,
a detectable  disease,  with  a  centralized  dengue
laboratory that  provides  dengue  testing  for  all  Bar-
badians free  of  charge.  The  objective  of  this  study
was to  describe  the  seroepidemiology  of dengue
in this  country  in  a  select  population  of  febrile
a
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rendemic  for  dengue.  The  age  of  infection  is  likely  to
ildren  who  are  more  likely  to  have  severe  dengue  in  the
ziz  University  for  Health  Sciences.  Published  by  Elsevier
ersons  suspected  and  tested  for  dengue  over  an
-year period.
aterial and methods
tudy design and study population
his  is  a retrospective  study.  The  study  population
onsisted of  all  febrile  persons  who  presented  to
ny of  the  health  care  facilities  in  Barbados  and
ho were  suspected  and  investigated  for  dengue.
ll age  groups  were  included  in  this  study.  In this
ountry,  dengue  is  a notiﬁable  disease,  and  the
inistry  of  health  has  established  written  guide-
ines for  suspecting  and  investigating  dengue  that
re based  on  the  guidelines  from  the  World  Health
rganization.  These  guidelines  are  circulated  to  all
octors periodically.  Febrile  patients  may  present
o the  state-run  primary  health  centers,  to  the
fﬁces  of  medical  practitioners  across  the  island,
r to  the  emergency  department  of  the  Queen  Eliz-
beth Hospital  (QEH).  If  suspected  to  have  dengue,
he patient  is  examined  for  dengue  by  the  attend-
ng physicians,  including  dengue  IgM  and  IgG  tests.
he request  form  for  IgM  and  IgG  antibody  testing
equires  detailed  patient  demographics,  including
ge, gender  and  home  address.  Additionally,  the
orms require  clinical  details  including  date  of onset
f the  illness,  date  of  sampling,  list  of  all  clinical
anifestations,  any  pre-existing  chronic  medical  or
urgical conditions,  whether  the  person  is  being
reated  as  ambulatory  patient  or  as  an  inpatient
t a hospital,  and  the  site  of  care  where  the  samp-
ing was  done.  The  attending  physician  ﬁlled  out
he dengue  request  form  that  accompanied  the
lood sample  to  the  laboratory.  All  dengue  serology
ests  were  performed  free  of  charge  at  a central
engue laboratory  for  the  entire  country.  Suspected
ases in  which  neither  IgM  nor  IgG  results  were
vailable were  excluded  from  further  analysis.  The
tudy period  extended  from  January  2006  through
ecember 2013.  The  study  was  approved  by  the
nstitutional  Review  Board  for  ethics  in  human  stud-
es at  the  University  of  the  West  Indies  (Cave  Hill)
nd the  Ethics  Committee  of  the  QEH.
The  dengue  laboratory  routinely  maintained  all
emographic  and  clinical  information  entered  in
T bril
t
p
I
d
t
t
l
s
t
M
t
t
w
p
f
c
f
e
o
I
e
M
A
c
d
o
t
d
d
b
t
w
f
a
t
t
2
4
a
s
a
r
t
H
a
o
O
8
n
O
p
t
4
ﬁ
t
1
d
p
8
a
6
a
p
o
n
l
d
a
(
a
t
i
T
u
a
s
b
l
s
f
o
a
D
A
b
l
a
a
f
I
ﬁ
d
[
o
ﬁ
d
t
t
p
T
w
w
phe  patterns  of  dengue  IgM  and  IgG  antibodies  in  fe
he  dengue  test  request  form  for  all  of  the  sus-
ected dengue  patients  tested  for  the  anti-dengue
gM and  IgG  antibodies  in  a  Microsoft  Access
atabase. All  of  the  patients’  information  con-
ained  in  the  request  form  and  the  results  of
he tests  were  entered  into  the  database  by  the
aboratory  clerk  to  avoid  any  bias.  Data  for  this
tudy  were  extracted  from  the  database  main-
ained by  the  dengue  laboratory  and  entered  into  a
icrosoft Access  database.  Extracted  data  included
he patient’s  age  and  gender,  date  of  onset  of
he illness,  date  of  testing,  the  test  results,  and
hether  the  patient  was  cared  for  as  an  ambulatory
atient or  as  an  inpatient  at  a  hospital.  All  entries
or the  serology  test  requests  in  suspected  dengue
ases were  included,  irrespective  of  the  test  results
or  the  IgM  or  IgG  antibodies.  Once  again,  the  data
xtraction  for  this  study  was  performed  by  the  lab-
ratory clerk  to  avoid  bias.  Patients  for  whom  the
gM or  the  IgG  test  results  were  not  available  were
xcluded from  further  analysis.
ethods
s  a routine  procedure  for  all  suspected  dengue
ases, 3—5  ml  of  clotted  blood  was  drawn  for
engue IgM  and  IgG  serological  studies  at  the  time
f presentation  to  the  health  care  facility  and  sent
o the  centralized  dengue  laboratory  on  the  same
ay. If  the  initial  sample  was  taken  during  the  ﬁrst  3
ays of  the  illness  and  tested  negative  for  IgM  anti-
odies, a  repeat  sample  was  drawn  after  day  5  of
he illness  for  repeat  IgM  testing.  This  cut-off  time
as established  based  on  our  preliminary  ﬁndings
rom  data  analyzed  for  the  period  between  2000
nd 2005,  which  showed  that  the  majority  of  the
esting was  performed  on  day  4 of  the  illness  and
hat the  proportions  of  samples  positive  on  days  1,
 or  3 were  signiﬁcantly  lower  than  those  on  day
, day  5 and  after  day  5.  This  also  showed  that
lthough the  proportion  of  positivity  was  higher  for
amples  after  day  ﬁve  when  compared  to  days  4
nd 5,  it  was  not  statistically  signiﬁcant.  A  ﬁnal
eport  from  this  analysis,  which  includes  samples
hrough 2013,  is  under  preparation  for  publication.
owever, not  all  of  the  persons  who  tested  IgM  neg-
tive on  the  ﬁrst  sample  taken  during  the  ﬁrst  3  days
f the  illness  had  a  repeat  sample  for  IgM  testing.
verall, there  were  5872  persons  (70.7%  of  the  total
296 persons  tested  for  IgM  at  any  time  of  the  ill-
ess) who  tested  IgM  negative  on  the  ﬁrst  sample.
f those  who  tested  IgM  negative  on  the  ﬁrst  sam-
le, 4245  samples  were  taken  on  day  4  or  later  in
he illness  (64.9%  of  the  6541  samples  taken  on  day
 or  later)  and  1627  samples  were  taken  during  the
rst 3  days  of  the  illness  (95.3%  of  the  1755  samples
p
M
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aken  during  ﬁrst  3 days  of  the  illness).  Out  of  the
627 negative  IgM  samples  taken  during  the  ﬁrst  3
ays of  the  illness,  1444  (88.7%)  had  a repeat  sam-
le taken  after  day  5  of  the  illness  for  IgM  testing,
31 (57.5%  of  those  who  had  a  repeat  sample  taken
fter day  5 of  the  illness)  were  still  negative  and
13 (42.5%  of  those  who  had  a  repeat  sample  taken
fter day  5  of  the  illness)  seroconverted  to  IgM
ositive. The  remaining  183  (11.3%)  samples  taken
n the  ﬁrst  3  days  of  the  illness  and  which  were
egative on  the  ﬁrst  tests  were  not  retested.  Sero-
ogical  tests  were  performed  for  the  detection  of
engue IgM  and  IgG  antibodies  using  a  commercially
vailable Enzyme  Linked  Immuno-Sorbent  Assay
ELISA) kit.  Dengue  IgM  capture  DxSelect  ELISA
nd Dengue  IgG  DxSelect  ELISA  (Focus  Diagnos-
ics, Cypruss,  CA)  were  used.  The  manufacturer’s
nstructions  were  followed  for  the  testing  process.
his commercially  available  assay  has  been  eval-
ated and  was  found  to  be  sufﬁciently  sensitive
nd speciﬁc  for  the  sero-diagnosis  in  clinical  serum
amples  [17].
All  of  the  patients  were  managed  supportively
y the  attending  physician  using  recent  WHO  guide-
ines for  the  management  of  dengue  [18].  Following
tandard practice  in  this  country,  all  cases  of  severe
orms of  dengue  or  those  at  risk  for  a  severe  form
f dengue  were  referred  to  the  QEH  for  admission
nd further  supportive  management.
eﬁnitions
 probable  [suspected]  case  of  dengue  was  deﬁned
y the  presence  of  fever  with  two  or  more  of  the  fol-
owing features:  rash,  nausea  and  vomiting,  aches
nd pains,  positive  tourniquet  test,  leucopenia  and
ny one  of  the  warning  signs  or  any  of  the  criteria
or severe  dengue  [18]. The  presence  of  a positive
gM antibody  in  the  blood  was  considered  to  con-
rm a recent  dengue  infection.  Recent  conﬁrmed
engue was  classiﬁed  as  a  Primary  or  Secondary
sequential] case  based  on  the  absence  or  presence
f positive  IgG  in  the  samples  collected  during  the
rst 5  days  of  the  illness  from  its  clinical  onset.  Past
engue was  deﬁned  by  the  presence  of  IgG  titer  in
he blood  sample  collected  during  the  ﬁrst  5  days  of
he illness  and  a negative  IgM  titer  in  the  blood  sam-
le collected  at any  time  after  day  4  of  the  illness.
he symptomatic  conﬁrmed  dengue  infection  rate
as calculated  by  dividing  the  number  of  persons
ith symptomatic  conﬁrmed  dengue  by  the  total
opulation  and  was  expressed  per  thousand  persons
er year.
All data  were  stored  in  a password-secured
icrosoft  Access  database  to  which  only  the  authors
ad access.  Data  were  analyzed  using  the  SPSS
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statistical  package  and  tables  and  graphs  were
generated  using  the  same  software.  We  used  the
chi-square  test  to  determine  the  signiﬁcant  differ-
ence in  categorical  variables.  A  P value  of  less  than
0.05 was  considered  signiﬁcant.  All  of  the  95%  con-
ﬁdence  intervals  were  corrected  for  continuity.
Results
During  the  8-year  study  period,  there  were  a total
of 8432  febrile  persons  who  were  suspected  and
investigated  for  dengue.  The  annual  incidence  of
probable dengue  ranged  from  1.3/1000  population
(378 cases)  in  2009  to  6.8/1000  population  (1931
cases)  in  2013.  The  median  duration  of  symptoms
suggestive of  dengue  at  the  time  of  blood  samp-
ling was  4 days  (range  2—5  days).  An  overview  of
the analysis  of  serology  data  of  suspected  dengue
patients who  were  investigated  during  the  study
period  is  shown  in  Table  1.  Approximately  8296
(98.4%) cases  had  a  documented  IgM  result,  7227
(85.7%)  cases  had  an  IgG  result,  and  7091  (84.1%)
suspected cases  had  full  dengue  serology  (both  the
IgM and  IgG)  status.
The  age  of  the  patients  with  suspected  dengue
ranged from  less  than  1 year  to  101  years  (mean
age 29.8  years,  median  age  26  years,  SD  =  21.0).
Among  the  suspected  dengue  cases,  there  were
4599 females  and  3849  males,  with  a  male  to
female  ratio  of  0.84.  The  mean  age  for  the  females
was 30.6  years,  and  the  mean  age  for  males  was
28.9 years  (P  =  0.0006).  A  plot  of  the  number  of
suspected cases  against  the  age  showed  a  dispro-
portionately higher  number  during  the  ﬁrst  2  years
of life,  followed  by  a  sharp  fall  and  then  a  gradual
rise in  numbers  in  the  age  range  of  10—25  years,  fol-
lowed by  a  negative  exponential  smoothing  of  the
graph for  both  males  and  females.
Of the  8296  cases  that  were  tested  for  IgM  anti-
bodies, 3037  (36.6%;  95%  CI  =  ±8.3%)  cases  tested
positive  and  were  conﬁrmed  to  have  recent  dengue.
In the  age  groups  <5  years,  5—20  years  and  >20
years, 23.3%,  39.6%  and  35.5%  had  acute  infection,
respectively.  No  signiﬁcant  difference  was  noted  in
the proportion  of  suspected  cases  that  were  pos-
itive for  IgM  antibodies  when  analyzed  for  males
and females  (P  =  0.95)  and  for  various  age  groups
(P =  0.33).  However,  if  we  excluded  the  group  above
85 years  old  (as  there  were  fewer  observations  in
this group),  there  was  a  signiﬁcant  positive  correla-
tion between  the  proportion  of  suspected  cases  that
2were IgM  positive  and  the  patients’  age  (r =  0.15,
P = 0.0003).
Of the  7227  suspected  cases  that  had  docu-
mented IgG  results,  5473  (75.7%;  95%  CI  = ±2.57%)
f
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ere  positive  for  IgG  antibodies  in  the  sample
aken during  ﬁrst  5  days  of  their  illness.  Fig.  1 is
 plot  of  the  proportion  of  suspected  cases  that
ere IgG  positive  against  age.  In  the  age  groups
5 years,  5—20  years  and  >20  years,  31.2%,  65.2%
nd 86.6%  had  past  infection,  respectively.  For  the
ge group  over  80  years  (n  = 126),  90.4%  of  probable
engue cases  who  were  investigated  had  a  posi-
ive IgG  in  their  serum  sample  taken  during  the
rst 5 days  of  their  illness.  In  the  age  groups  <5
ears, 5—20  years  and  >20  years,  45.0%,  18.8%  and
.2%, respectively,  had  no  evidence  of  recent  or
ast dengue.
Fig.  2  is  a plot  of  the  different  serodiagnoses
gainst  the  age  of  the  patients.  During  the  ﬁrst
 years  of  life  (excluding  the  ﬁrst  year),  between
0% and  20%  of  febrile  children  suspected  and
nvestigated for  dengue  had  positive  IgM  titers
nd negative  IgG  titers  (categorized  as  recent  pri-
ary dengue),  between  5  and  10%  had  positive
gM and  IgG  titers  (categorized  as  recent  secondary
engue), approximately  5%  had  positive  IgG  titers
nd negative  IgM  titers  (past  dengue),  and  between
5% and  65%  had  negative  IgM  and  negative  IgG
iters (no  recent  or  past  dengue).  The  ﬁrst  year  was
n exception,  as  close  to  50%  of  febrile  children
uspected and  investigated  for  dengue  had  posi-
ive IgG  titers  with  negative  IgM  titers.  In  persons
ver 20  years  who  were  suspected  and  investigated
or dengue,  between  20%  and  50%  had  positive
gM and  IgG  titers  (secondary  dengue),  less  than
0% had  positive  IgM  titers  and  negative  IgG  titers
primary  dengue),  and  50%  to  60%  had  negative
gM titers  and  positive  IgG  titers  (past  dengue).
hese differences  in  the  serodiagnosis  among  the
ifferent  age  groups  were  statistically  signiﬁcant
P =  0.01).
An  analysis  of  the  time  trends  in  the  serodi-
gnosis over  the  study  period  is  shown  in  Fig.  3.
he years  2006,  2008,  2009,  2010  and  2011  were
onsidered  non-epidemic  years,  whereas  the  years
007, 2012  and  2013  were  epidemic  years.  Dur-
ng the  8-year  study  period,  an  overall  16.1%
95% CI  =  15.2%,  17.0%)  of  febrile  persons  sus-
ected  and  investigated  for  dengue  failed  to  show
ny evidence  of  current  or  previous  dengue  (neg-
tive IgM  and  IgG  titers),  and  this  proportion
anged between  13.1%  (2013)  and  20.1%  (2009).
o signiﬁcant  time  trend  was  noted.  Overall,  8.1%
95% CI  = 7.5%,  8.8%)  had  recent  primary  infection
nd 28.8%  (95%  CI  =  27.8%,  29.9%)  had  secondary
nfection. During  the  non-epidemic  years,  of  the
ebrile persons  suspected  and  screened  for  dengue,
.9%  (95%  CI  =  4.1%,  5.8%)  had  recent  primary
nfection and  23.4%  (95%  CI  =  21.8%,  25.1%)  had  sec-
ndary infection.  The  corresponding  ﬁgures  for  the
The  patterns  of  dengue  IgM  and  IgG  antibodies  in  febrile  persons  in  Barbados  587
Table  1  Summary  of  the  immunoglobulin  ﬁndings  among  febrile  persons  with  suspected  dengue  in  Barbados,
2006—2013.
Dengue  IgM  Dengue  IgG  N  Ntotal
Negative  Positive  Negative  Positive
Incomplete  Ig  status
Recent  dengue?  —  no  previous  dengue  38  38
Recent  dengue?  —  previous  dengue  98  98
No  dengue  —  previous?  787  787
Recent  dengue  —  previous?  418  418
Total  1341
Complete  Ig  status
No  dengue  —  no  previous  dengue 1141  1141  1141
No  dengue  —  previous  dengue  3331  3331  3331
Recent  dengue  —  no  previous  dengue  575  575  575
Recent  dengue  —  previous  dengue  2044  2044  2044
Total  7091
Totals  5259  3037  1754  5473  8432
To
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rpidemic  years  were  10.0%  (95%  CI  = 9.2%,  10.9%)
nd 32.0%  (95%  CI  =  30.7%,  33.4%).  The  differ-
nce in  the  proportion  of  primary  and  secondary
ases during  the  non-epidemic  and  epidemic  years
as signiﬁcant  (P  <  0.003).  Overall,  47.0%  (95%
I = 45.8%,  48.2%)  of  those  tested  for  dengue  had
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Figure  1  Dengue  IgG  seroprevalencetal  IgMs  8296  Total  IgGs  7227
vidence  of  past  infection  without  any  evidence  of
ecent infection.  In  the  non-epidemic  and  epidemic
ears,  55.2%  (95%  CI  =  53.3%,  57.1%)  and  42.1%  (95%
I = 40.7%,  43.6%),  respectively,  had  past  infection
n the  absence  of  recent  infection.  The  difference
etween the  epidemic  and  non-epidemic  years
 by  age  in  Barbados,  2006—2013.
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ile  p
DFigure  2  Serological  diagnosis  by  age  group  among  febr
was  signiﬁcant  (P  <  0.0001).  Over  the  study  period,
37.0% (213/575;  95%  CI  30.95%,  39.94%)  and  37.9%
(774/2044;  95%  CI  = 34.64%,  39.24%)  of  all  con-
ﬁrmed  recent  primary  and  secondary  (sequential)
cases, respectively,  were  among  the  hospitalized
persons.
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Figure  3  Time  trend  in  serological  diagnosis  among  febrile  persons  with  suspected  dengue  in  Barbados,  2006—2013.
iscussionhis  study  of  the  pattern  of  IgM  and  IgG  responses
mong the  febrile  persons  who  were  suspected
o have  dengue  and  presented  to  the  various
ealth care  facilities  throughout  Barbados  is the
ersons  with  suspected  dengue  in  Barbados,  2006—2013.
T bril
ﬁ
f
a
t
u
o
ﬁ
f
i
a
w
D
s
2
a
d
t
a
C
o
w
a
C
b
a
d
E
a
d
m
s
t
o
c
s
i
w
g
t
t
I
a
t
t
a
s
c
p
g
t
a
o
l
o
p
p
i
R
s
t
p
w
p
p
e
t
e
i
o
g
6
(
r
C
a
h
s
v
l
i
I
r
t
t
l
c
o
[
s
c
w
t
a
>
i
T
a
L
u
h
g
i
a
hhe  patterns  of  dengue  IgM  and  IgG  antibodies  in  fe
rst  long-term  seroepidemiologic  study  reported
rom an  English-speaking  Caribbean  country.  The
ge-speciﬁc  seroprevalence  ﬁndings  and  the  time
rend in  the  seroprevalence  in  this  select  pop-
lation provide  useful  insight  into  the  dynamics
f dengue  transmission  in  this  population.  These
ndings  should  provide  useful  predictions  of  the
uture course  and  the  nature  of  dengue  epidemics
n this  country  and  in  the  Caribbean  region  as
 whole.
In  Barbados,  in  the  eighties  and  early  nineties
hen dengue  re-emerged  in  the  Caribbean,  only
ENV 2  was  reported,  which  was  responsible  for
poradic  cases.  However,  by  1995,  DENV  1,  DENV
 and  DENV  4  were  in  circulation  in  this  country
nd in  the  wider  English  Caribbean.  In  this  region,
engue  became  a  major  public  health  problem  in
he mid-nineties,  with  two  major  epidemics  in  1995
nd 1997  [19,20].  DENV  3  reemerged  in  the  English
aribbean  in  1997  and  by  2002  had  spread  to  most
f the  Caribbean  [20]. In  2001,  all  four  serotypes
ere co-circulating  in  this  country,  and  there  was
n epidemic  in  2002,  which  was  a  part  of  the  pan-
aribbean pandemic  [13,20].  In  the  time  period
etween 2003  and  2007,  DENV  3  caused  almost
ll cases  of  dengue  in  this  country  [21].  Barba-
os, one  of  the  popular  tourist  destinations  in  the
astern  Caribbean,  has  a  tropical  climate  with  high
nnual rainfall  and  humidity.  This  climate  is  con-
ucive to  the  propagation  of  the  Aedes  aegypti
osquito and  results  in  a  high  population  den-
ity, which  provides  favorable  conditions  for  dengue
ransmission.
The ﬁndings  from  this  study  show  that  by  the  age
f 18,  over  80%  of  the  studied  population  has  sero-
onverted  and  by  25  years,  more  than  90%  of  the
tudy population  was  positive  for  the  IgG  antibod-
es to  one  or  more  dengue  serotypes  (Fig.  1).  There
as  a  dip  noted  in  the  IgG  seroprevalence  in  the  age
roup from  65  to  75  years.  This  may  be  reﬂective  of
he lesser  likelihood  of  the  persons  in  this  age  group
o present  for  care  and  be  examined  for  dengue.
n Barbados,  the  age  of  retirement  is  65  years,
nd thereafter,  there  is  no  need  for  the  manda-
ory health  certiﬁcation  after  illness  that  applies
o working  people.  However,  with  further  advancing
ge beyond  75  years,  health  issues  are  taken  more
eriously,  and  individuals  are  more  likely  to  seek
are for  suspected  dengue;  therefore,  the  sero-
revalence  returned  to  the  higher  levels  seen  in  age
roups younger  than  65.  Nearly  100%  of  persons  in
heir eighties  and  older  were  positive  for  the  IgG
ntibodies. A  similar  pattern  of  high  seroprevalence
f IgG  was  reported  in  a  short-term  seropreva-
ence study  of  the  sentinel  population  from  two
ther  neighboring  Caribbean  countries  [12,14].  The
c
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attern  of  seroconversion  seen  among  a select
opulation of  children  attending  the  medical  facil-
ty for  gastrointestinal  symptoms  in  the  Dominican
epublic [12]  and  among  febrile  persons  who  were
creened  for  dengue  in  Jamaica  [14]  was  similar  to
he pattern  seen  in  this  study.  Interestingly,  the
attern of  IgG  seroprevalence  seen  in  our  study
as also  similar  to  the  patterns  of  high  IgG  sero-
revalence  that  were  reported  in  population-based
rospective  studies  from  some  of  the  other  highly
ndemic  countries  in  the  Americas  [11,22—25]  and
hose of  other  highly  endemic  countries  in  south-
ast Asia  [26—28].
The  rate  of  seroconversion  over  a  period  of  time
s a rough  indicator  of  the  intensity  of  transmission
f the  virus  in  the  population  [29,30]. In  the  age
roups  <5  years,  5—20  years  and  >20  years,  31.2%,
5.2% and  86.6%,  respectively,  had  past  infection
IgG positive).  This  compares  well  with  the  ﬁgures
eported  from  Jamaica,  another  English-speaking
aribbean  country  [14].  In  this  study  population,
t least  20%  of  children  were  found  to  have  already
ad dengue  infection  and  seroconverted  by  their
econd  birthday;  this  would  translate  to  a  serocon-
ersion rate  of  10%  per  year  in  the  ﬁrst  few  years  of
ife (Fig.  1).  However,  some  of  these  IgG-positive
nfants may  have  had  trans-placental  transfer  of
gG from  their  mother.  Nevertheless,  this  may  be
eﬂective of  a  fairly  high  rate  of  transmission  of
he virus  and  a  high  vector  density  in  this  popula-
ion. A  high  rate  of  seroconversion  with  age  with  a
ower mean  age  of  infection  seen  in  this  population
ould be  interpreted  as  a measure  of  the  intensity
f the  endemicity  of  this  infection  in  this  population
29—31].  The  pattern  of  high  IgG  seroprevalence
een in  this  population  in  the  presence  of  the  co-
irculation  of  all  4  dengue  serotypes  is  in  keeping
ith the  high  proportion  of secondary  infec-
ions seen  in  this  study,  especially  among  young
dults.
In the  age  groups  <5  years,  5—20  years  and
20 years,  23.3%,  39.6%  and  35.5%  had  acute
nfection (IgM  and/or  NS1  positive),  respectively.
hese ﬁgures  are  higher  than  those  reported  from
nother  seroprevalence  study  from  this  region  [14].
ess than  10%  of  the  adults  in  this  study  pop-
lation (febrile  persons  with  suspected  dengue)
ad evidence  of  recent  infection  that  was  cate-
orized as  primary  (IgG  negative  and  IgM  positive
n the  acute  serum  sample),  whereas  between  30
nd 40%  of  febrile  adults  with  suspected  dengue
ad secondary  infection  (Fig.  2).  In  other  words,
urrent dengue  was  three  to  four  times  more
ikely to  be  a  secondary  than  a primary  infec-
ion. A  similarly  higher  proportion  of  secondary
nfection has  been  reported  from  other  countries
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known  to be  hyperendemic  for  dengue  [23,27,32].
A continuing  high  incidence  of  recent  infection
in adults  in  the  presence  of  high  IgG  seropreva-
lence would  mean  that  this  population  is  immune
to only  some  of  the  dengue  serotypes.  There-
fore, further  sequential  dengue  infection  with
heterologous serotypes  in  partially  immune  indi-
viduals would  potentially  increase  the  risk  of  more
severe  forms  of  dengue  such  as  DHF  in  the  future
[1,2,5,33,34].
A  notable  observation  in  this  study  was  very
high IgG  seropositivity  among  the  older  adults  over
the entire  period  of  this  study  in  the  face  of  co-
circulation  of  all  four  serotypes  of  dengue  and
continuing acute  infection  in  this  population.  There
are at  least  three  important  inferences  that  could
be drawn  from  this  observation.  First,  the  older
adults  in  this  population  should  be  nearing  their
saturation  point  of  immunity  to  multiple  serotypes
of dengue.  Thus,  older  adults  should  have  a very
low susceptibility  to  further  acute  infection  with
any of  the  dengue  serotypes  in  the  future  [30].
This is  already  reﬂected  in  the  very  low  num-
bers of  acute  infection  in  the  age  group  older
than 80  in  this  study  (Fig.  3).  Second,  in  the
face of  continuing  circulation  of  multiple  dengue
serotypes, the  age  of  infection  is  bound  to  shift
to the  lower  age  group  in  the  coming  years  in  this
population.  This  is  a  phenomenon  that  is  very  sim-
ilar to  those  experienced  in  many  of  the  highly
endemic countries  of  southeast  Asia  and  the  Ameri-
cas [11,31,35].  Third,  this  would  mean  that  the  risk
of severe  dengue  from  sequential  infection  should
have already  reached  a  plateau  and  that  there
may not  be  further  increases  in  the  proportion  of
severe forms  of  dengue  in  this  population  in  the
future.
One of  the  major  limitations  of  this  study  was
the lack  of  data  on  the  serotype-speciﬁc  antibody
identiﬁcation due  to  the  lack  of  testing  facili-
ties. As  a  result,  we  were  not  able  to  detect  the
multiplicity of  previous  infections  or  ascertain  the
sequence of  past  infection  and  its  relationship  with
disease severity  in  this  population.  The  unavail-
ability of  data  on  the  total  number  of  all  febrile
persons seen  over  the  study  period  makes  it difﬁ-
cult to  assess  the  degree  of  completeness  of  the
screening process,  and  it  is  likely  that  this  study
may have  underestimated  the  actual  prevalence  of
dengue infection  in  this  population.  The  retrospec-
tive nature  of  this  study  is  another  limitation  of  this
study. The  retrospective  nature  of  the  study  was
also responsible  for  the  signiﬁcant  amount  of  miss-
ing data.  We  could  not  subject  the  ﬁndings  from
this study  to  any  external  validation  due  to  the
lack of  similar  types  of  data  from  this  population  or
A
W
sA.  Kumar,  A.L.  Nielsen
rom  the  other  English  Caribbean  countries  in  this
egion.
In summary,  the  results  of this  sentinel  study
rom the  English  Caribbean  show  that  the  sero-
revalence  of  dengue-speciﬁc  IgG  in  this  repre-
entative sample  of  the  population  is  very  high
nd stable  over  the  fairly  long  study  period.  The
ear-saturated  seroprevalence  of  IgG  seen  in  this
opulation  of  febrile  adult  patients  could  translate
nto increased  infection  among  younger  children
n contrast  to  the  present  scenario  in  which  the
ajority  of  dengue  cases  in  the  population  occur  in
ounger adults.  Additionally,  in  the  future,  dengue
s likely  to  present  with  more  severe  disease  pat-
erns in  younger  adults  and  children  who  have  a
igniﬁcantly  high  IgG  level  but  are  not  yet  at  sat-
ration levels,  making  them  prone  to  more  severe
isease patterns  associated  with  sequential  infec-
ions. Therefore,  this  study  encourages  the  vector
ontrol  and  epidemic  containment  as  well  as  the
ormulation  of  standard  local  guidelines  for  the
arly detection  and  optimal  management  of  dengue
n this  country.  However,  there  is  a need  to  fur-
her explore  the  serotype-speciﬁc  seroprevalence,
hich is  useful  in  the  early  prediction  of  epidemics.
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